Azlocillin pharmacokinetics in patients with cystic fibrosis.

The pharmacokinetics of azlocillin were studied in 10 cystic fibrosis patients, ranging in age from 11 to 28 years. The patients received a 9- to 23-day course of 350 mg of azlocillin per kg in four or six divided daily doses in combination with am aminoglycoside. Blood and urine samples were collec...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Bosso, J A, Saxon, B A, Herbst, J J, Matsen, J M
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1984
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185602/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732230/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.5.630
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!